None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Males and females aged greater than 30 and less than 60 years old 2.Subjects who usually have 3 balanced meals a day except persons who eat fermented soybeans or granola everyday 3.Subjects with BMI greater than 23 and less than 30 kg/m^2 except persons under treatment of obesity 4.Subjects who usually drink alcohol once or twice a week at most 5.Subjets giving written informed consent
Exclusion criteria
Exclusion criteria: 1.Subjects who takes oral medication affecting obesity, hyperlipidemia and lipid metabolism 2.Subjects who suffer a severe illness in liver, cardiovascular, respiratory, endocrine, metabolism and allergy 3.Subjects who are not able to stop to take in food or supplement affecting obesity, hyperlipidemia and lipid metabolism 4.Subjects who have under treatment or a history of drug addiction and/or alcoholism 5.Subjects who have a metal component in the abdomen 6.Subjects who have a cardiac pacemaker 7.Subjects who have food allergy 8.Subjects who were diagnosed as familial hyperlipidemia 9.Pregnant and lactating female, or who wish to get pregnant during the study period 10. Subjects who is already participating or participated within 1 month in other clinical trials, subjects planning to participate during this examination period 11.Subjects who are ineligible due to physician's judgment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal visceral fat area, abdominal subcutaneous fat area, and abdominal total fat area, at 12weeks after intake | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight(BMI), abdominal circumherence, fasting blood sugar level and serum lipids(total cholesterol, LDL-cholesterol, Triglycerides), at 6 and 12weeks after intake Measurement of intestinal flora and adiponectin(polymer), at 12weeks Defecation frequency and stool output | — |
Countries
Japan
Contacts
KSO Corporation Sales department